Health

Financire de Tubize – Annual report 2025

Annual Report 2025Regulated information 21 March 2026 The board of directors of Financière de Tubize has established the 2025 annual…

2 weeks ago

Garaherb Claims Evaluated: Complete Scientific Investigation of Ingredients’ Effectiveness

Aurora, CO, March 20, 2026 (GLOBE NEWSWIRE) -- Editor's Note: The terms "Complete Scientific Investigation" and "Effectiveness" in the headline…

2 weeks ago

Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results

March 20, 2026 13:30 ET  | Source: SANUWAVE Health, Inc. EDEN PRAIRIE, Minn., March 20, 2026 (GLOBE NEWSWIRE) -- Sanuwave…

2 weeks ago

Disclosure of a transparency notification from Aberdeen Group plc

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 20 March 2026 – 6 PM CET Disclosure of a transparency notification from Aberdeen…

2 weeks ago

Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcytes 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate

March 18, 2026 19:34 ET  | Source: Vaxcyte, Inc. Based on the Strength of Unprecedented Results from the Positive Phase…

2 weeks ago

2026 MAP Awards presented to 20 organizations for high performance in revenue cycle

CHICAGO, March 18, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) announced the 2026 winners of the MAP…

2 weeks ago

VitalHub Reports Fourth Quarter 2025 Results

Annual Recurring Revenue (“ARR”)⁽¹⁾ up 35% YoY to $96.1 millionTotal Revenue up 52% YoY to $31.4 millionAdjusted EBITDA⁽¹⁾ up 47%…

2 weeks ago

SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants

March 17, 2026 22:46 ET  | Source: SAB Biotherapeutics, Inc. MIAMI, March 17, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc.…

2 weeks ago

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

March 17, 2026 22:46 ET  | Source: CytomX Therapeutics Inc. SOUTH SAN FRANCISCO, Calif., March 17, 2026 (GLOBE NEWSWIRE) --…

2 weeks ago